
Sign up to save your podcasts
Or
Send us a text
Nick talks to Dr. Berra Yazar-Klosinski, the Chief Science Officer for the Multidisciplinary Association for Psychedelic Studies (MAPS). Berra talked about the results of MAPS' recent Phase III clinical trials for treating severe PTSD, how these studies are conducted, and what we know about the underlying biology of Post-Traumatic Stress Disorder (PTSD) and the drug MDMA.
*Not medical advice.
Support the show
All episodes, show notes, transcripts, and more at the M&M Substack
Affiliates:
For all the ways you can support my efforts
4.8
7373 ratings
Send us a text
Nick talks to Dr. Berra Yazar-Klosinski, the Chief Science Officer for the Multidisciplinary Association for Psychedelic Studies (MAPS). Berra talked about the results of MAPS' recent Phase III clinical trials for treating severe PTSD, how these studies are conducted, and what we know about the underlying biology of Post-Traumatic Stress Disorder (PTSD) and the drug MDMA.
*Not medical advice.
Support the show
All episodes, show notes, transcripts, and more at the M&M Substack
Affiliates:
For all the ways you can support my efforts
5,022 Listeners
2,338 Listeners
1,319 Listeners
485 Listeners
652 Listeners
765 Listeners
335 Listeners
1,118 Listeners
907 Listeners
200 Listeners
64 Listeners
100 Listeners
69 Listeners
113 Listeners
0 Listeners